| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1988) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | RH248G8V27 |
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C21H37GdN4O15 |
| Molecular Weight | 742.79 |
| AlogP | None |
| Hydrogen Bond Acceptor | None |
| Hydrogen Bond Donor | None |
| Number of Rotational Bond | None |
| Polar Surface Area | None |
| Molecular species | None |
| Aromatic Rings | None |
| Heavy Atoms | None |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| None | Diagnostic agent |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 2 | D009369 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL1200431 |
| FDA SRS | RH248G8V27 |
| PubChem | 450511 |
CONTENTS